AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Aug 06, 2021

Oncodermatology takes the stage at Fox Lectureship

Rather than interrupting cancer treatment, oncodermatologists can help treat the side effects.


Mario E. Lacouture, MD, FAAD
Mario E. Lacouture, MD, FAAD

Oncodermatology has evolved rapidly over the last 15 years, bringing the skills and expertise of dermatologists to the care of patients undergoing cancer treatments and to those who are plagued by the side effects affecting the hair, skin, and nails.

These advances align well with the Everett C. Fox, MD,  Award and Lectureship celebrating innovative thinking. Mario E. Lacouture, MD, FAAD, delivered the lecture during the Summer Meeting’s Plenary (P151). Dr. Lacouture is a full member and director of the oncodermatology program at Memorial Sloan-Kettering Cancer Center in New York.

“Oncodermatology was created for the 20 million people diagnosed with cancer every year all over the world and the more than 35 million survivors living with a prior cancer history,” Dr. Lacouture said. “The evolution of oncodermatology has impacted how cancer patients are cared for through scientific and clinical advances. Oncodermatology provides patients with early and rapid access to dermatologists across the country, improving quality of life and ensuring patients are able to continue to receive cancer therapies.”

Several things have happened in the last two decades to bring oncodermatology to the forefront of cancer care, Dr. Lacouture said. In the past, when patients presented with cancer treatment-related side effects affecting hair, skin, and nails, oncologists would interrupt the cancer treatment and restart it later when the patient could tolerate another treatment. If the pattern of side effects continued, oncologists would simply stop the use of that drug and look for another.

“Without dermatologic support, oncologists have limited resources to manage dermatologic conditions,” Dr. Lacouture said. “In up to a third of patients with skin side effects, cancer drugs may be stopped.”

The remedy, he said, is same-day visits with an oncodermatologist to treat the side effect. That only happens as dermatologists gain more knowledge in community and academic centers so that patients can receive rapid access and effective therapies for side effects, he said. According to Dr. Lacouture, there are currently 30 to 50 oncodermatologists spread across 80% of U.S. cancer centers.

Other developments in the last decade, he said, include an increase in clinical trials specifically directed toward treating the aggressive effects of chemotherapy and immunotherapy. For example, Dr. Lacouture said, clinical trials led to FDA approval of two devices that cool the scalp and reduce hair loss due to chemotherapy. Studies show the devices work in 50-70% of patients.

The push for oncodermatology has since led to the formation of the Oncodermatology Society this year, with the mission of advancing cancer care through skin health. The first textbook on oncodermatology was published in 2012.

“One in two men and one in three women will be diagnosed with cancer at some point in their lives,” Dr. Lacouture said. “Oncodermatology exists to improve skin-related quality of life, optimize the use of cancer treatments by ensuring tolerability, and establish dermatologists as integral partners in the care of those touched by cancer.”

Interesting Stories
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
More in Summer Meeting 2021
Peter Lio, MD, FAAD
Summer Meeting 2021
The secrets of minimizing pain
Aug 11, 2021
Lawrence S. Chan, MD, FAAD
Summer Meeting 2021
Biomedical advancements impact dermatologic diagnosis and treatment
Aug 11, 2021
Todd Schlesinger, MD, FAAD
Summer Meeting 2021
Update on managing advanced skin cancer
Aug 11, 2021
Hensin Tsao, MD, PhD, FAAD
Summer Meeting 2021
HPV vax, psoriasis biologics, and caregiver quality of life highlight FiRST session
Aug 11, 2021
07e
Summer Meeting 2021
Summer Meeting packed a welcome punch
Aug 11, 2021
Julie Gerberding, MD, MPH
Summer Meeting 2021
COVID-19: A “predictable surprise”
Aug 06, 2021
Aimee Payne, MD, PhD, FAAD
Summer Meeting 2021
Frost Lectureship traces mPV treatment’s path from lab to clinical trial
Aug 06, 2021
2020 Gold Medal Presentation | Professor R. Rox Anderson, MD (left), Lancer Endowed Chair in Dermatology, Harvard Medical School and Director, Wellman Center for Photomedicine at Mass. General Hospital. 2021 Gold Medal Presentation | Dirk Michael Elston, MD, FAAD (right), Medical University of South Carolina.
Summer Meeting 2021
Two physicians honored with AAD Gold Medal awards
Aug 05, 2021
Alina G. Bridges, DO, FAAD
Summer Meeting 2021
New science, technology, and dedication improve dermatopathology
Aug 05, 2021
Sm21 F008 1526e
Summer Meeting 2021
How to have mindful, effective conversations with patients
Aug 05, 2021
Sergey Rekhtman, MD, FAAD, PharmD, MPH, and Sheila Shaigany, MD, FAAD
Summer Meeting 2021
Lessons from COVID-19’s cutaneous manifestations
Aug 05, 2021
Charlene Lam, MD, MPH, FAAD
Summer Meeting 2021
“Uninvite” disaster by planning
Aug 05, 2021
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.